Pfizer weighs sale of consumer healthcare business

loading...


Pfizer weighs sale of consumer healthcare business
(Reuters) – Pfizer said on Tuesday it was considering the sale or spin-off of its consumer healthcare business, shaking up the industry and potentially putting a headache pill to lip balm operation worth as much as $14 billion up for grabs.


Source: Business

Reply

Pin It on Pinterest

Shares
Share This
loading...